Cancer risk in patients with four non-specific symptoms: a decade of research and implications for practice

Journal article

In England, the most common route to cancer diagnosis is via general practice, 1 with similar patterns seen across the UK and similar international jurisdictions. 2 Timely recognition of suspected cancers in primary care, appropriate testing, and referral along managed urgent cancer pathways can improve patient outcomes through earlier diagnosis.3 Often, site-specific alarm symptoms, for example, haemoptysis for lung cancer, have a clear referral pathway. However, over half of patients diagnosed with cancer present with non-specific symptoms (NSS).4,5 These include unexplained weight loss, fatigue, abdominal symptoms, nausea, vomiting, appetite loss, and non-specific pain. Determining onward management of this patient group poses a challenge for primary care. This analysis aims to outline the challenges of NSS management, critically appraise research from the past decade related to four common NSS (unexplained weight loss, abdominal pain, bloating, and fatigue), and consider the opportunities for the future management of NSS. The challengeNSS are usually associated with a lower risk for individual cancer sites than site-specific alarm symptoms. Patients diagnosed with cancer who present with NSS experience prolonged intervals from presentation to diagnosis, later-stage diagnosis, and diagnosis via emergency presentation.6 National cancer referral guidelines, such as the National Institute for Health and Care Excellence (NICE) NG12 used in England and Wales, employ cancer risk thresholds based on signs and symptoms. NICE NG12 generally employs a 3% threshold, which means that patients with a cancer risk above this threshold should be considered for urgent specialist investigation or referral. Non-specific symptoms often will not reach this threshold for referral.7 The NICE NG12 guideline was comprehensively updated in 2015, at which time there was little research investigating cancer risk in people presenting with NSS, and no managed care pathways for this cohort in the UK.There has been much research and service development over the past decade to address this challenge. NSS pathways have been implemented across the UK to provide a route for GPs to refer patients exhibiting NSS onto a managed pathway. England's national NSS pathway launched in 2019 and completed rollout in 2024.Similar pathways exist across Wales (rapid diagnostic clinics), Scotland (rapid cancer.

Authors: Williamson, C; Behal, A; White, B; Rafiq, M; Harrison, S

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Royal College of General Practitioners
• Journal: British Journal of General Practice
• Volume: 76
• Issue: 771
• Pages: 472-476
• Publication date: 2026-10-01
• Acceptance date: 2026-05-18
• DOI: 10.3399/bjgp.2026.0088
• EISSN: 1478-5242
• ISSN: 0960-1643
• Language: English
• Keywords: primary care; cancer risk; non-specific symptoms; cancer screening; general practice; early cancer detection